Business Description
Royalty Pharma is a New York-based company that purchases royalty interests from drug developers and provides funding to advance new medicines. Founded in 1996, it holds royalty stakes in dozens of approved and pipeline treatments spanning areas such as cancer, rare diseases, neuroscience, and diabetes. This model allows the company to generate returns while helping bring important therapies to patients.
